IMAC Holdings Reports Year End 2022 Financial Results and Corporate Update
31 mars 2023 20h00 HE
|
IMAC Holdings, Inc.
Revenue increased 14% annually driven by greater adoption of medical treatments. BRENTWOOD, Tenn., March 31, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), a...
IMAC Holdings and Brain Scientific Announce a Strategic Merger to Create Synergistic End-To-End Neurological Solution
20 mars 2023 07h30 HE
|
IMAC Holdings, Inc.
Combined company will provide total solutions, from diagnosis to treatment, for patients with neurological disorders including Parkinson’s, Alzheimer's, and stroke. BRENTWOOD, Tenn. and LAKEWOOD...
IMAC Holdings, Inc announces the sale of The BackSpace
01 mars 2023 09h30 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., March 01, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), announces today it has completed the sale of The BackSpace for an undisclosed price...
IMAC Holdings Announces Third Quarter Results
15 nov. 2022 06h00 HE
|
IMAC Holdings, Inc.
Company Reports Sixth Consecutive Quarter of Comparable Revenue Growth BRENTWOOD, Tenn., Nov. 15, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” “BACK” or the “Company”), today...
IMAC Holdings, Inc. Launches E-Commerce Website for Vitamin and Supplement Line
03 nov. 2022 08h30 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Nov. 03, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), announces today it has launched an e-commerce platform to retail its vitamin and...
IMAC Holdings, Inc. Hosts Hall of Fame Athlete Panel at the Evoke Conference to Launch Whole Food Supplement Partnership
21 oct. 2022 10h30 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Oct. 21, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), announces today it is partnering with Evoke Chiropractic Coaching to educate and...
IMAC Holdings, Inc. Announces Completion of Third Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease
09 sept. 2022 09h22 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Sept. 09, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or “the Company”), today announces it has completed the third cohort of its Phase 1 clinical trial for...
Biote Announces Strategic Partnership with IMAC Holdings, Inc.
07 sept. 2022 08h30 HE
|
IMAC Holdings, Inc.
Biote Method to be available in IMAC outpatient medical clinics IRVING, TX, Sept. 07, 2022 (GLOBE NEWSWIRE) -- biote Corp. (Nasdaq: BTMD)(“Biote” or the “Company”), a high growth, differentiated...
IMAC Holdings, Inc. Announces Addition of Medical Weight Loss Services to IMAC Regeneration Centers
01 sept. 2022 09h44 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Sept. 01, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), announces today it is accepting patients for medical weight loss services at IMAC...
IMAC Holdings, Inc. Announces Closing of $3.9 Million Registered Direct and Private Placement Offerings
16 août 2022 16h00 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Aug. 16, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative...